CO6341560A2 - Proceso para la preparacion de derivados de pirimidina sustituidos. - Google Patents

Proceso para la preparacion de derivados de pirimidina sustituidos.

Info

Publication number
CO6341560A2
CO6341560A2 CO11000461A CO11000461A CO6341560A2 CO 6341560 A2 CO6341560 A2 CO 6341560A2 CO 11000461 A CO11000461 A CO 11000461A CO 11000461 A CO11000461 A CO 11000461A CO 6341560 A2 CO6341560 A2 CO 6341560A2
Authority
CO
Colombia
Prior art keywords
preparation
substituted
group
hydrogen
pirimidine derivatives
Prior art date
Application number
CO11000461A
Other languages
English (en)
Inventor
Cancian Sergio Cesco
Hongfeng Chen
Tong Xiao
Kirk L Sorgi
Daniel J Pippel
David C Palmer
Christopher M Mapes
Neelakandha Mani
Jeffrey S Grimm
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41464882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6341560(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CO6341560A2 publication Critical patent/CO6341560A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invención está dirigida a un proceso para la preparación de compuestos de Fórmula (I)en dondeL1 es CN;Rc se selecciona del grupo que consiste de H, metilo, etilo, propilo, isopropilo, -CF3, ciclopropilo, y ciclobutilo;R6 es hidrógeno;R8 se selecciona del grupo que consiste de hidrógeno y alquilo de C1-4;Z se selecciona del grupo que consiste de N y CH;n es 1 ó 2;R9, R10 y R11 se seleccionan, independientemente, del grupo que consiste de hidrógeno y alquilo de C1-4 y sales farmacéuticamente aceptables de éstos."
CO11000461A 2008-06-30 2011-01-04 Proceso para la preparacion de derivados de pirimidina sustituidos. CO6341560A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7675208P 2008-06-30 2008-06-30

Publications (1)

Publication Number Publication Date
CO6341560A2 true CO6341560A2 (es) 2011-11-21

Family

ID=41464882

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11000461A CO6341560A2 (es) 2008-06-30 2011-01-04 Proceso para la preparacion de derivados de pirimidina sustituidos.

Country Status (36)

Country Link
US (6) US8309720B2 (es)
EP (5) EP2924025A1 (es)
JP (1) JP5416768B2 (es)
KR (1) KR101675354B1 (es)
CN (1) CN102137672B (es)
AR (1) AR072396A1 (es)
AU (1) AU2009267156B2 (es)
BR (1) BRPI0913644A2 (es)
CA (1) CA2729733C (es)
CO (1) CO6341560A2 (es)
CY (1) CY1116134T1 (es)
DK (1) DK2310012T3 (es)
EA (1) EA019361B1 (es)
EC (1) ECSP11010745A (es)
ES (1) ES2538135T3 (es)
HK (4) HK1156857A1 (es)
HR (1) HRP20150576T1 (es)
HU (1) HUE024949T2 (es)
IL (4) IL210214A (es)
JO (1) JO3043B1 (es)
ME (1) ME02154B (es)
MX (1) MX2011000080A (es)
MY (1) MY150601A (es)
NI (1) NI201000232A (es)
NZ (1) NZ590170A (es)
PE (1) PE20110163A1 (es)
PL (1) PL2310012T3 (es)
PT (1) PT2310012E (es)
RS (1) RS53985B1 (es)
SI (1) SI2310012T1 (es)
SV (1) SV2011003788A (es)
TW (3) TWI481603B (es)
UA (1) UA106724C2 (es)
UY (1) UY31949A (es)
WO (1) WO2010002774A1 (es)
ZA (1) ZA201100759B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2007752T3 (da) 2006-03-31 2010-11-15 Janssen Pharmaceutica Nv Benzimidazol-2-yl-pyrimidiner og -pyraziner som modulatorer af histamin H4-receptoren
ME02154B (me) 2008-06-30 2015-10-20 Janssen Pharmaceutica Nv Proces za pripremu supstituisanih derivata pirimidina
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
JP5574294B2 (ja) * 2010-11-04 2014-08-20 独立行政法人科学技術振興機構 光磁気記録媒体及び光磁気記録方法
CN105025898B (zh) 2013-03-06 2018-01-23 詹森药业有限公司 组胺h4受体的苯并咪唑‑2‑基嘧啶调节剂
US10202337B2 (en) 2014-03-28 2019-02-12 Kaneka Corporation Method for producing tri-carbobenzoxy-arginine
SG11201903871TA (en) 2016-11-03 2019-05-30 Bristol Myers Squibb Co Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005852A (en) 1959-12-22 1961-10-24 Gen Aniline & Film Corp Production of sulfoxides and sulfones
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4191828A (en) * 1976-04-14 1980-03-04 Richardson-Merrell Inc. Process for preparing 2-(2,2-dicyclohexylethyl)piperidine
US4190601A (en) * 1978-05-31 1980-02-26 Union Carbide Corporation Production of tertiary amines by reductive alkylation
JPS5942396A (ja) * 1982-09-02 1984-03-08 Ishihara Sangyo Kaisha Ltd リン酸アミド誘導体およびそれらを含有する殺虫、殺ダニ、殺線虫剤
JPS6130576A (ja) 1984-07-24 1986-02-12 Ube Ind Ltd ２−アミノ−５−シアノピリミジンの製法
US5786373A (en) * 1992-10-14 1998-07-28 Merck & Co., Inc. Fibrinogen receptor antagonists
GB9422391D0 (en) 1994-11-05 1995-01-04 Solvay Interox Ltd Oxidation of organosulphur compounds
JP2002503662A (ja) 1998-02-17 2002-02-05 テュラリク インコーポレイテッド 抗ウイルス性ピリミジン誘導体
GB9914258D0 (en) * 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
US6372743B1 (en) 1999-09-30 2002-04-16 Neurogen Corporation Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
CA2411155C (en) 2000-07-21 2009-12-08 Syngenta Participations Ag Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
WO2002064096A2 (en) 2001-02-16 2002-08-22 Tularik Inc. Methods of using pyrimidine-based antiviral agents
US20050107400A1 (en) * 2001-03-30 2005-05-19 Boyd Leslie F. Use of pyrazolopyridines as therapeutic compounds
ATE323706T1 (de) * 2001-12-17 2006-05-15 Smithkline Beecham Corp Pyrazolopyridazinderivate
TWI270542B (en) 2002-02-07 2007-01-11 Sumitomo Chemical Co Method for preparing sulfone or sulfoxide compound
DE60329030D1 (de) * 2002-12-04 2009-10-08 Ore Pharmaceuticals Inc Melanocortin-rezeptormodulatoren
JP2006525261A (ja) * 2003-05-05 2006-11-09 エフ．ホフマン−ラ　ロシュ　アーゲー Ｃｒｆ活性を有する縮合ピリミジン誘導体
US7786291B2 (en) 2004-10-27 2010-08-31 Schering Corporation Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
WO2006138304A2 (en) 2005-06-14 2006-12-28 Taigen Biotechnology Pyrimidine compounds
JP5058159B2 (ja) * 2005-07-06 2012-10-24 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 分離マトリックスの製造方法
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
CN101032483B (zh) * 2006-03-09 2011-05-04 陈德桂 调节雄激素受体活性的乙内酰脲衍生物及其应用
DK2007752T3 (da) * 2006-03-31 2010-11-15 Janssen Pharmaceutica Nv Benzimidazol-2-yl-pyrimidiner og -pyraziner som modulatorer af histamin H4-receptoren
DE602007008859D1 (de) * 2006-03-31 2010-10-14 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyridine als modulatoren des histamin-h4-rezeptors
ME02154B (me) 2008-06-30 2015-10-20 Janssen Pharmaceutica Nv Proces za pripremu supstituisanih derivata pirimidina
AU2009267159B2 (en) * 2008-06-30 2014-05-15 Janssen Pharmaceutica Nv Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives

Also Published As

Publication number Publication date
EA201170113A1 (ru) 2011-08-30
JP2011526910A (ja) 2011-10-20
CA2729733C (en) 2016-10-25
DK2310012T3 (da) 2015-03-30
TW201012810A (en) 2010-04-01
ES2538135T3 (es) 2015-06-17
US20140121374A1 (en) 2014-05-01
PL2310012T3 (pl) 2015-08-31
KR101675354B1 (ko) 2016-11-11
TW201420583A (zh) 2014-06-01
EP2310012A1 (en) 2011-04-20
AU2009267156B2 (en) 2015-05-28
HK1201441A1 (en) 2015-09-04
SV2011003788A (es) 2011-02-08
NZ590170A (en) 2012-04-27
CN102137672B (zh) 2014-03-26
HK1214590A1 (zh) 2016-07-29
PT2310012E (pt) 2015-04-02
TWI481603B (zh) 2015-04-21
US9079884B2 (en) 2015-07-14
US20130225816A1 (en) 2013-08-29
EA019361B1 (ru) 2014-03-31
IL235571A (en) 2016-09-29
PE20110163A1 (es) 2011-03-28
KR20110023901A (ko) 2011-03-08
EP2924035A1 (en) 2015-09-30
UY31949A (es) 2010-01-29
ZA201100759B (en) 2012-07-25
JO3043B1 (ar) 2016-09-05
EP2924023A1 (en) 2015-09-30
HK1215434A1 (zh) 2016-08-26
US20100004450A1 (en) 2010-01-07
CA2729733A1 (en) 2010-01-07
RS53985B1 (en) 2015-10-30
IL210214A0 (en) 2011-03-31
US9079883B2 (en) 2015-07-14
CY1116134T1 (el) 2017-02-08
IL210214A (en) 2016-07-31
TW201433568A (zh) 2014-09-01
EP2924025A1 (en) 2015-09-30
ME02154B (me) 2015-10-20
UA106724C2 (uk) 2014-10-10
EP2769721A3 (en) 2015-04-01
IL235570A (en) 2016-08-31
HUE024949T2 (en) 2016-02-29
AR072396A1 (es) 2010-08-25
HK1156857A1 (en) 2012-06-22
IL235572A (en) 2016-09-29
MY150601A (en) 2014-01-30
US8309720B2 (en) 2012-11-13
EP2310012B1 (en) 2015-03-04
MX2011000080A (es) 2011-03-02
SI2310012T1 (sl) 2015-06-30
HRP20150576T1 (hr) 2015-09-11
US20140066624A1 (en) 2014-03-06
AU2009267156A1 (en) 2010-01-07
NI201000232A (es) 2011-09-07
EP2310012A4 (en) 2012-06-20
US20140073795A1 (en) 2014-03-13
BRPI0913644A2 (pt) 2015-11-24
CN102137672A (zh) 2011-07-27
US9006432B2 (en) 2015-04-14
EP2769721A2 (en) 2014-08-27
US20130053561A1 (en) 2013-02-28
WO2010002774A1 (en) 2010-01-07
US9359327B2 (en) 2016-06-07
ECSP11010745A (es) 2011-02-28
US9079882B2 (en) 2015-07-14
TWI498326B (zh) 2015-09-01
JP5416768B2 (ja) 2014-02-12

Similar Documents

Publication Publication Date Title
CO6341560A2 (es) Proceso para la preparacion de derivados de pirimidina sustituidos.
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
MY172924A (en) Neprilysin inhibitors
PH12015500457A1 (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
PH12014501283A1 (en) 4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
EA201490807A1 (ru) Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1
MX2011009146A (es) Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh.
CR10671A (es) Compuestos azabiciclicos como inhibidores de la recaptacion de monoaminas
MX344933B (es) Compuestos de lipoílo y su uso para tratar lesión isquémica.
PH12015502429A1 (en) Dicarboxylic acid compound
CO6341626A2 (es) Proceso para la preparacion de derivados de benzoimidazol-2-il pirimidina
MY183326A (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
UY32055A (es) Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones.
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
EA201270421A1 (ru) 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт
MY165634A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
TN2014000519A1 (en) Pyrimidinone derivatives as antimalarial agents
PE20141168A1 (es) Derivados de pirazolidin-3-ona
NZ601284A (en) Sulfone compounds as 5-ht6 receptor ligands
EA201290344A1 (ru) БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ЛИГАНДОВ αβНИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА

Legal Events

Date Code Title Description
FC Application refused